Glucose Testing - Research and Markets - RSS Feed

Blood Glucose Meters & Strips - A Global Update of Market Trends & Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:18 GMT

Blood glucose levels or blood sugar levels represent the measurement, which indicates whether or not a person is suffering from diabetes. Blood glucose monitoring can be performed at home using a variety of blood monitoring products available in the market, which usually include glucometers and test strips. Glucose self-monitoring remains a very viable option for a vast majority of diabetic patients, and is increasingly considered as the standard of care. Over the years, glucose-monitoring meters have undergone vast change, with recent entries featuring non-revolutionary and small-scale improvements.

These and other market data and trends are presented in "Blood Glucose Meters & Strips: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses

The Top 20 Non-Invasive Blood Glucose Monitoring Device Companies Worldwide

press@researchandmarkets.com — Tue, 08 Sep 2009 13:24:41 GMT

Did you know? - Diabetes currently affects 246 million people worldwide and is expected to affect 380 million by 2025 - In 2007, the five countries with the largest numbers of people with diabetes were India (40 9 million), China (39 8 million), the United States (19 2 million), Russia (9 6 million)...

The Top 60 Blood Glucose Monitoring Device Companies Worldwide

press@researchandmarkets.com — Tue, 25 Aug 2009 07:50:59 GMT

Worldwide Glucose Self-Testing Market (Meters, Strips and Lancets), 2000-2012

press@researchandmarkets.com — Fri, 12 Jan 2007 16:40:20 GMT

This Database Table is a one-page table of hard-to-find numerical information. Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors. Over 600 database tables are now available from Research and Markets.

A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: Pharmaceuticals, Healthcare and Medical Devices, and Biotechnology.

U.S. Diabetes Glucose Self-Monitoring Devices Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:07 GMT

Test Strip Margins and Revenues Decide Profitability in 'Free Meter' Market

Often described as a 'free meter market', the glucose self-monitoring business is characterized by heavy discounts for the meters component of the self-monitoring kits. Manufacturers accept this market dynamic as an industry norm. They expect the sales of test strips to generate revenues and profit margins that compensate for the cost of meter discounts. For manufacturers, the challenge lies in identifying 'ideal' diabetic patients when giving away the meters, those who will use the meter to test frequently and generate repeat sales of test strips. In addition, both manufacturers and healthcare professionals need to continue to educate patients about the benefits of glucose self-monitoring in order to develop more 'ideal' patients.

This Frost & Sullivan study analyses the North American market for diabetes glucose self-monitoring devices. It provides a valuable analysis of market drivers, restraints and forecasts, identifying the areas of growth. The study covers self-monitoring meters and test strips, along with new non- and minimally invasive technologies.

Consumer-driven Marketing and High Cost of Business Transform Competitive Landscape

Research has shown that while health care professionals are highly influential in the initial purchase decision, subsequent upgrades or purchases are often based on multiple influences that include the media, says the author of the study. Today, companies such as TheraSense, LifeScan and Roche spend considerable amounts in direct-to-consumer advertising to generate recall and recognition for their brands. It allows them to communicate their differentiation to a high percentage of consumers that self select glucose self-monitoring kits. As more and more companies advertise direct-to-consumers, marketing prowess is becoming a key success factor.

Need for Expensive Research and Development (R&D) Capability Drives Consolidation Within the Industry

Be

U.S. Glucose Monitoring Markets and Emerging Technologies

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:06 GMT

Emerging Glucose Monitoring Technologies Edge Closer to Market Realization
Constant innovations in glucose monitoring technologies are being driven by the need for more frequent testing to better understand individual patients’ glucose level trends and enhance personal treatment protocols. New glucose monitoring technologies are working toward creating a system that is non-invasive as well as accurate, easy to use, portable, stylish, and low-cost. The emerging technology segments of the market is projected to contribute up to 6.5 percent of the overall revenues by 2011 and can pose a challenge to traditional technologies such as glucose strips. The increasing awareness of the burden of diabetes on the U.S. healthcare system is expected to spark further development of better glucose monitoring solutions.
This Frost & Sullivan research service analyzes the U.S. glucose monitoring market, segmenting it into glucose strips, glucose meters, and emerging glucose monitoring technologies. It discusses the various market trends and opportunities while providing in-depth analysis of market share, forecasts, drivers, restraints, and revenues. Strategic recommendations offered in the study enable companies to align their positioning strategies to benefit from the changing market and obtain maximum return on investment.
Rising Healthcare Costs Drive New Product Development Efforts in the Glucose Monitoring Market
Rapid expansions of the direct and indirect costs associated with diabetes are compelling Medicare and other healthcare insurance companies to take steps to control further growth in disease prevalence. The American Diabetes Association has reported that the diabetes treatment expenses on the U.S. healthcare system totaled $132 billion in 2002 of which, $91.8 billion made up the direct medical expenses. Such statistics only emphasize the need for more efforts to increase diagnosis of the undiagnosed diabetic population, and they are expected to consequ

South Korean Diabetes Diagnostics Markets

press@researchandmarkets.com — Mon, 08 Jan 2007 16:03:34 GMT

This Frost & Sullivan research service titled South Korean Diabetes Diagnostics Markets provides a complete market analysis with Market Engineering measurements, revenue forecasts, market revenues, technology trends, market share analysis, and end-user analysis In this study, Frost & Sullivan's...

Japanese Diabetes Diagnostics Markets

press@researchandmarkets.com — Mon, 08 Jan 2007 15:32:01 GMT

This Frost & Sullivan research service entitled Japanese Diabetes Diagnostics Markets provides a complete market analysis with Market Engineering measurements, revenue forecasts, market revenues, technology trends, market share analysis, and end-user analysis In this research service, Frost &...

Chinese Diabetes Diagnostics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:40:59 GMT

This analysis is available through our Pharmaceutical and Clinical Diagnostics Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data as well as many interactive features including Analyst Inquiry Time and Client Councils.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research service:

- Laboratory diabetes diagnostics
- POCT diabetes diagnostics

Technologies

The following technologies are covered in this research:

- Automation: Laboratory automation can be defined broadly as any device, software, or process that improves the efficiency of the laboratory.
- Integration: The act of integrating various automated tasks into a continuous process.
- Total Lab Automation (TLA): The definition of TLA is the combination of several instruments, consolidated instruments, workcells, integrated workcells, or integrated modular workcells that are coupled to a specimen management and transportation system as well as a process control software component to automate a large percent of laboratory work.
- Point-of-Care Testing (POCT): Pathology investigation by or on behalf of the treating medical practitioner on-site. It is a diagnostic testing conducted close to the site where clinical care is delivered.

Market Overview

Large Untapped Potential Drives Future Growth of Chinese Diabetes Diagnostics Markets

Increasing incidences of diabetes in China leading to higher volumes of diagnostic tests is the primary driver for the growth of the Chinese diabetes diagnostics markets. These markets grew by 6.8 per cent from 2004 to 2005 and are expected to see a compound annual growth rate (CAGR) of 9.8 percent from 2005-2012. Considering that only about 15.0 per cent of the Chinese diabetic population of 30.0 million is diagnosed with this disease and also that an alarmingly high 85.0 percent remains undiagnosed, these mar

Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets

press@researchandmarkets.com — Thu, 16 Nov 2006 14:41:52 GMT

Developing Countries Emerging as Key Markets for Diabetes Monitoring Devices

The demand for glucose self-monitoring devices has seen tremendous growth in recent years. Developing countries are rapidly emerging as important markets for these devices, spurred by growing awareness, availability of sophisticated self-monitoring technologies, and greater purchasing power. This is evident from the strong growth experienced by participants in these countries during the 2002-2003 time period even as they were undergoing a relatively slow growth phase in the U.S. market.

This strategic analysis service (SAS) is a visual presentation of the latest trends in the global diabetes glucose monitoring devices markets and their three segments: glucose meters, glucose test strips, and continuous glucose monitoring systems. It examines the significant challenges faced by participants and recommends strategies to overcome the same. Market metrics include segment-wise revenue forecasts, pricing trends, identification of emerging opportunities, and detailed information on competitive positioning of leading companies.

A ‘Free Meter’ Market Relies Heavily on Test Strips for Higher Profitability

The glucose self-monitoring devices business has often been described as a ‘free meter market’ because of the heavy discounts offered on glucose meters. In most cases, glucose meters, priced between $45 and $100 are distributed free with the purchase of multiple packs of glucose test strips. Due to this, equipment manufacturers consider meters as ‘loss leaders’ and try to amortize their cost over a specific time period. The challenge for manufacturers lies in patient selection and distribution of free meters to these ‘ideal’ patients that are likely to use test strips and meters frequently and generate repeat sales.

Consumer-driven Marketing Campaigns - Essential, though Expensive

Key market participants have traditionally focused their selling

Blood Glucose Testing and Diabetes Management

press@researchandmarkets.com — Thu, 17 Aug 2006 09:09:57 GMT

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to...

2004 U.S. Hospital Point-of-Care Blood Glucose Survey

press@researchandmarkets.com — Mon, 28 Feb 2005 17:27:41 GMT

This in-depth report provides market share as well as actual vendor and instrument customer satisfaction data for the POC Blood Glucose market segment.

This report provides:
- Coverage of the Point-of-Care Blood Glucose hospital testing market
- Highlights of important overall trends in POC

Normal Glucose Values—Fasting State

press@researchandmarkets.com — Sat, 21 Dec 2002 15:14:00 GMT

U.S. Point of Care Glucose Testing Market, 1997-2007

press@researchandmarkets.com — Sat, 21 Dec 2002 15:14:00 GMT

Market Dynamics 2001: Diabetes

press@researchandmarkets.com — Sat, 05 Oct 2002 12:19:00 GMT

Few non-infectious diseases are growing as rapidly as type II diabetes. More than 37 million people in seven major pharmaceutical markets now have

Drugs of Tomorrow 2001: Diabetes

press@researchandmarkets.com — Sat, 05 Oct 2002 12:19:00 GMT

The key unmet need in the diabetes market is centred around drug delivery formulations. Insulin, not only the gold standard treatment for type I diabetes, but also an increasingly recommended treatment for type II diabetes, must be administered by injecti

Glucose Monitoring

press@researchandmarkets.com — Sat, 05 Oct 2002 12:19:00 GMT

Currently valued at approximately $3bn, the glucose meter market is expected to grow rapidly over the next five years due to the launch of innovative